US Patent:
20220226481, Jul 21, 2022
Inventors:
- Boston MA, US
Tinghu Zhang - Brookline MA, US
Eric Fischer - Chestnut Hill MA, US
Katherine Donovan - Boston MA, US
Emily Erickson - Brookline MA, US
Alex Toker - Dedham MA, US
Assignee:
DANA-FARBER CANCER INSTITUTE, INC. - Boston MA
BETH ISRAEL DEACONESS MEDICAL CENTER, INC. - Boston MA
International Classification:
A61K 47/55
A61K 47/54
A61K 31/337
A61P 35/00
Abstract:
Disclosed are bifunctional compounds comprising a GDC-0068 analog that binds AKT isoforms AKT1, 2 and 3, pharmaceutical compositions, and methods for treating diseases or conditions mediated by dysfunctional AKT activity.